Full Name
Aman Preet Badhwar
Speaker Bio
Dr. AmanPreet Badhwar is an Assistant Professor at the University of Montreal, Faculty of Medicine,
Department of Pharmacology and Physiology, and a researcher at the Centre de recherche de l'Institut universitaire de gériatrie de Montréal (CRIUGM). She is a member of CCNA Teams 7 and 9, Trainee Liaison for Team 9, and past chair of the CCNA Trainee Society. From the undergraduate to postdoc level, Dr. Badhwar’s path has been to study neurological disease by combining different data types, starting with small-scale genetics and brain imaging early in her career, and progressively moving to “big data” in Alzheimer’s disease (AD). Dr. Badhwar’s multi-institutional PhD work combined the themes of multimodal research (neuroimaging, proteomics, and measures of neurovascular coupling), to tease apart the contributions of neuronal and cerebrovascular damage on cognitive dysfunction in AD, and the impact of drug treatment on these components. Elements of Dr. Badhwar’s postdoctoral work sought to characterize the heterogeneity in AD cohorts using resting-state functional MRI connectivity, an emerging biomarker of synaptic or network dysfunction in AD. These investigations contributed to the understanding of connectivity measures in AD from three different perspectives: group-level connectivity, connectivity subtypes, and individual connectivity fingerprint. Another important aspect of Dr. Badhwar’s postdoctoral work was focused on establishing a biomarker roadmap for the Canadian framework for generating multiomics biomarkers from imaging, genomics, metabolomics and other modalities. Dr. Badhwar currently directs the Multiomics Investigation of Neurodegenerative Diseases (MIND) Lab that focuses on integrating observations from in-vivo imaging and molecular ‘omics’ in the study of AD and other neurodegenerative diseases, with the goal of discovering new biomarkers and therapeutic targets, and improving methods to speed the drug discovery process. Dr. Badhwar has held several prestigious scholarships over the years, and was recently awarded the Chercheur-boursiers Junior 1 from the Fonds de recherche du Québec.
Department of Pharmacology and Physiology, and a researcher at the Centre de recherche de l'Institut universitaire de gériatrie de Montréal (CRIUGM). She is a member of CCNA Teams 7 and 9, Trainee Liaison for Team 9, and past chair of the CCNA Trainee Society. From the undergraduate to postdoc level, Dr. Badhwar’s path has been to study neurological disease by combining different data types, starting with small-scale genetics and brain imaging early in her career, and progressively moving to “big data” in Alzheimer’s disease (AD). Dr. Badhwar’s multi-institutional PhD work combined the themes of multimodal research (neuroimaging, proteomics, and measures of neurovascular coupling), to tease apart the contributions of neuronal and cerebrovascular damage on cognitive dysfunction in AD, and the impact of drug treatment on these components. Elements of Dr. Badhwar’s postdoctoral work sought to characterize the heterogeneity in AD cohorts using resting-state functional MRI connectivity, an emerging biomarker of synaptic or network dysfunction in AD. These investigations contributed to the understanding of connectivity measures in AD from three different perspectives: group-level connectivity, connectivity subtypes, and individual connectivity fingerprint. Another important aspect of Dr. Badhwar’s postdoctoral work was focused on establishing a biomarker roadmap for the Canadian framework for generating multiomics biomarkers from imaging, genomics, metabolomics and other modalities. Dr. Badhwar currently directs the Multiomics Investigation of Neurodegenerative Diseases (MIND) Lab that focuses on integrating observations from in-vivo imaging and molecular ‘omics’ in the study of AD and other neurodegenerative diseases, with the goal of discovering new biomarkers and therapeutic targets, and improving methods to speed the drug discovery process. Dr. Badhwar has held several prestigious scholarships over the years, and was recently awarded the Chercheur-boursiers Junior 1 from the Fonds de recherche du Québec.
Speaking At
